نتائج البحث

Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy.

• Authors : Satake, Tomoyuki^1,2 (AUTHOR) ; Morizane, Chigusa² (AUTHOR) ; Okada, Mao² (AUTHOR)

• Source: Cancer Medicine. Dec2024, Vol. 13 Issue 23, p1-9. 9p.

تفاصيل العنوان

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

• Authors : Hummingbird Bioscience

• Source: A Cancer Research UK Phase I/IIa Open Label, Dose Escalation and Expansion Trial of HMBD-001 (an Anti-HER3 Monoclonal Antibody) Given Intravenously As a Single Agent and

تفاصيل العنوان

Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer

• Authors : Daiichi Sankyo; Merck Sharp & Dohme LLC

• Source: Phase 1/2, Multicenter, Open-label, Multiple-Dose First-in-human Study of U3-1402, in Subjects With HER3 Positive Metastatic Breast Cancer

تفاصيل العنوان

HER3 receptor and its role in the therapeutic management of metastatic breast cancer

• Authors : Meiying Zhu; Minghui Yu; Yuan Meng

Subjects: Metastatic breast cancer; HER3; Targeted therapy

• Source: Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)

تفاصيل العنوان

Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy

• Authors : Tomoyuki Satake; Chigusa Morizane; Mao Okada

Subjects: cancer genome profiling; chemotherapy; HER3

• Source: Cancer Medicine, Vol 13, Iss 23, Pp n/a-n/a (2024)

تفاصيل العنوان

A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance

• Authors : Nicoleta Sinevici; Christine E. Edmonds; Brian N. Dontchos

Subjects: HER3; Neoadjuvant; Breast cancer

• Source: Breast Cancer Research, Vol 26, Iss 1, Pp 1-16 (2024)

تفاصيل العنوان

A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities

• Source: A Phase 1/2, Open Label, Multicenter Study to Investigate the Safety, Pharmacokinetics, and Efficacy of TAS0728, an Oral Covalent Binding Inhibitor of HER2, in Subjects With Advanced Solid Tumors With

تفاصيل العنوان

HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?

• Authors : Ann-Katharina Becker; Behrus Puladi; Kunpeng Xie

Subjects: Liposarcoma; HER3; ERBB3

• Source: World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-10 (2024)

تفاصيل العنوان

Targeting HER3 to overcome EGFR TKI resistance in NSCLC

• Authors : Chen, Qiuqiang; Jia, Gang; Zhang, Xilin

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

تفاصيل العنوان

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

• Authors : Chen, Qiuqiang; Jia, Gang; Zhang, Xilin

Subjects: Biochemistry and Cell Biology; Biomedical and Clinical Sciences; Biological Sciences

تفاصيل العنوان